Russia says Argentina approves Sputnik Light as standalone and booster vaccine
Argentina was one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine, but delays in deliveries led the country in August to offer second doses of Moderna and AstraZeneca vaccines to citizens who received the first dose of Russia's ..
December 7, 2021
by expresspharma
Argentina approves Sputnik Light Covid-19 shot as standalone and booster
Sputnik Light showed effectiveness as a universal boost when mixed with the vaccines of AstraZeneca, Sinopharm, Moderna and Cansino.
December 7, 2021
by Pharmaceutical-Technology
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effecti
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the interim results of the study in Argentina on heterogeneous regimens combining Sputnik Light ...
October 15, 2021
by prnasia
Moderna signs supply pact with Argentina for 20 million doses of its COVID-19 vaccine
Moderna announced a supply agreement with the government of Argentina for 20 million doses of Moderna’s COVID-19 vaccine or its updated variant booster vaccine candidate, if authorised, to begin delivery in the first quarter of 2022.
July 13, 2021
by expresspharma
COVID-19: US trials for drug made in Taiwan, China Region of China to be expanded
Golden Biotechnology said its drug candidate antroquinonol will enter Phase II trials in the US for treatment of severely ill COVID-19, pending authorisation by the authorities, in the third quarter, as reported Taipei Times.
June 7, 2021
by firstwordpharma
Argentina registers Russia’s Covid-19 vaccine Sputnik V
The Russian Direct Investment Fund (RDIF) has announced that the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT) has registered the Sputnik V vaccine against Covid-19.
December 25, 2020
by pharmaceutical-technology
Argentina and Mexico to make AstraZeneca COVID-19 vaccine for Latin America
The deal between AstraZeneca and mAbxience of the INSUD Group includes technology to initially produce 150 million doses of the vaccine for all of Latin America except Brazil.
August 14, 2020
by expresspharma
USA struggles and middle income countries could do more in tackling health inequality according to Oxfam report
A cluster of Latin American countries such as Costa Rica, Uruguay and Argentina, and a cluster of OECD countries with long-term commitments to public investment
November 20, 2018
by pharmafile
Argentina's Sinergium turns to cell-based technology for new vaccine production
Argentina's Sinergium Biotech, which is in a consortium to develop a Zika virus vaccine, intends to build a new plant that will use cell biology that can be utilized for a Zika vaccine or for the flu vaccine production it already does.
April 11, 2017
by fiercepharma